Ramos Perez JM, Patel KP, Loghavi S, Garcia-Manero G, et al. Value of measurable residual disease monitoring in patients with acute promyelocytic leukemia in the era of frontline 'chemotherapy-free' therapy. Leuk Lymphoma 2021 Oct 20:1-4. doi: 10.1080/10428194.2021.1992757.
PMID: 34668451